🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🆕 A comprehensive review classifies 80 invasive procedures into high and low bleeding risk for cirrhotic patients: 🔍 Agreement in 52/80: 17 high-risk & 35 low-risk ✅ Low-risk: platelet count >30x10^9/L safe ✅ High-risk: platelet count >50x10^9/L safe 🤔 30% of experts did

Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-…

New year, new reading materials!🎉 Let’s start 2024 with today’s #readoftheweek about a patient-specific CCA-on-chip platform, which could further elucidate the biological mechanisms involved in CCA and provide an efficient tool for personalised drug testing. Read here this🔓

📌Exploring the link between #PSC & #IBD 🤔. Are they one disease or two? 🧬 Mild inflammation in PSC + IBD, high cancer risk, and post-transplant issues complicate the picture. #GITwitter #LiverTwitter #MedTwitter #MedEd #medical 📑tinyurl.com/36y6a9vd my_UEG EASLnews

Meeting on portal hypertension and TIPS at Humanitas University Great talks and discussions with Annalisa Berzigotti Stella De Nicola Nicola Pugliese Ana Lleo Giovanni Perricone jaumebosch

Blown away by this 🔥session about #AI in #hepatology 🇨🇦Joint CDDW™-CLM Conference | #CDDWCLM2025 by 🌟 Jin Ge Nicola Pugliese Joseph C. Ahn, M.D. 🙌 If you miss it, join Jin Ge and me for 🔥#AI sessions Digestive Disease Week & AmericanTransplantCongress #LiverTwitter #generativeAI ChatGPT

🌟Proud to have been involved in Joint CDDW™-CLM Conference | #CDDWCLM2025 🇨🇦 Thanks to Giada Sebastiani and Alessio Aghemo for this opportunity

And like that, the field has changed for the better #LiverTwitter...! In less that a year we have: New steatotic liver disease nomenclature: journal-of-hepatology.eu/article/S0168-… MASLD/MASH research priorities: journal-of-hepatology.eu/article/S0168-… MASLD/MASH Action priorities: journals.lww.com/hep/fulltext/9…

#CGH4ALL CGH Let's Talk ChatGPT meets #NAFLD #MASLD 🌟15 Questions that patients w/ NAFLD ask 🧩3 independent entries on ChatGPT 🧐Reviewed by 10 experts & 1 patient advocate (moderate level of agreement among experts) 🎯What's next? Medicine-specific AI already on

Academic Medical Education Jörn Schattenberg Naim Alkhouri Aleksander Krag Maja Thiele FattyLiverAlliance Aurora Barberá Paul Brennan Elliot Tapper Manuel Romero-Gómez Juan M Pericas Dídac Mauricio Círculo Ecuestre EASLnews AASLD APASL News ALEH Asociación Española para el Estudio del Hígado Javier Crespo @HannesHagstrom Ajay Duseja Mazen Noureddin, MD, MHSc CaixaResearch INASL European Liver Patients' Association Liver Patients International (LPI) Maru Rinella MD Alina Allen Meena Bansal Delfina Boudou Camilla Dalby Hansen, MD, PhD Kicking off the global #NITsummit now with Dr Pere Gines of Hospital Clínic presenting #LiverScreen and LiverAim. Am incredibly proud to be part of the latter project, together with #SLDthinktank co-chair Jörn Schattenberg and experts across Europe. #LiverTwitter

È disponibile online la survey IG-IBD sulla gestione delle alterazioni degli enzimi epatici nei pazienti affetti da #IBD! Il vostro contributo è prezioso e richiede solo pochi minuti! it.surveymonkey.com/r/IG-IBDLiver

➡️Pleased to coauthor this excellent work! 🟢Language does not affect #ChatGPT ability to counsel #MASLD patients ❌Suboptimal accuracy on specialist referral Nicola Pugliese Humanitas Milano JPM_MDPI McGill_DOM Centre universitaire de santé McGill Research Institute of the MUHC (The Institute) CASL FRQ - secteur Santé mdpi.com/2075-4426/14/6…

❓Persistent and unexplained elevated #GGT❓ 🔎Discover what predicts #PSVD in our 🆕 paper🔥 on JHEP Reports 🔥 Alessio Aghemo Francesca Romana Ponziani Luca Valenti @CristianaBianco

What is the "digitally-quantified self" & it's relevance to MASLD? onlinelibrary.wiley.com/doi/10.1111/li… 🌡️Adoptive innovative monitoring platforms 🏷️Encourages self-monitoring and care 💊But when patient and provider awareness is low it, remains challenging. Jeffrey V. Lazarus Nicola Pugliese

In today’s #readoftheweek📚, the authors’ findings highlight the role of liver biopsy in elucidating the underlying pathology and aiding in the diagnosis of patients with persistent and unexplained GGT elevation. Read here this JHEP Reports article: jhep-reports.eu/article/S2589-… 🙏

Good news! The review article by Roberta D'Ambrosio, Alessio Aghemo Nicola Pugliese Maria Paola Anolli Humanitas Milano Policlinico di Milano has received over 500 views since publication! Read it here onlinelibrary.wiley.com/doi/10.1111/li… #ViewsMileston

Porto-sinusoidal vascular disorder (PSVD) encompasses a group of disorders characterized by lesions of the portal venules and sinusoids with clinical manifestations ranging from non-specific abnormalities in serum liver enzymes to clinically overt portal hypertension and related

Can chatGPT read liver biopsies? journals.lww.com/hepcomm/fullte… #EASL2025

🏃‍♂️🍎 Achieving meaningful weight loss in #MASLD remains a challenge — but certain factors predict better outcomes: 🔸 #GLP-1 therapy 🔸 #Nutrition support 🔸 BMI ≥ 30 kg/m² 🔸 Liver stiffness ≥ 10 kPa 🔸 Bilirubin ≥ 1.2 mg/dL 📖 #OpenAccess 👉 bit.ly/45T0mkq